Get started
Live feed
·
PRReleasevia Quantisnow
Opus Genetics Inc. logo

Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update

ByQuantisnow·Wall Street's wire, on your screen.
IRDOpus Genetics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IRD (Opus Genetics Inc.) and more on Quantisnow.